Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2,4-thiazolidinedione, 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-
2. 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-2,4-thiazolidinedione
3. Isaglitazone
4. Mcc 555
5. Mcc-555
6. Pgx 510
7. Pgx-510
8. Rwj-241947
9. Rwj241947
1. 161600-01-7
2. Mcc-555
3. Isaglitazone
4. Rwj-241947
5. Mcc 555
6. Pgx-510
7. Qov2jz647a
8. 5-((6-((2-fluorobenzyl)oxy)naphthalen-2-yl)methyl)thiazolidine-2,4-dione
9. 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-2,4-thiazolidinedione
10. 5-[[6-[(2-fluorophenyl)methoxy]naphthalen-2-yl]methyl]-1,3-thiazolidine-2,4-dione
11. 2,4-thiazolidinedione, 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-
12. Netoglitazone [usan]
13. (5rs)-5-((6-((2-fluorobenzyl)oxy)-2-naphthyl)methyl)thiazolidine-2,4-dione
14. Unii-qov2jz647a
15. Netoglitazone (usan/inn)
16. Netoglitazone [usan:inn]
17. Netoglitazone [inn]
18. Mls006010812
19. Chembl93747
20. Schembl142658
21. Gtpl2707
22. Mcc555
23. Dtxsid5043712
24. Db09199
25. 5-({6-[(2-fluorobenzyl)oxy]naphthalen-2-yl}methyl)-1,3-thiazolidine-2,4-dione
26. Ncgc00370742-06
27. As-16475
28. Smr004701744
29. Hy-100428
30. Cs-0018884
31. D05150
32. A899346
33. Q6999822
| Molecular Weight | 381.4 g/mol |
|---|---|
| Molecular Formula | C21H16FNO3S |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 381.08349271 g/mol |
| Monoisotopic Mass | 381.08349271 g/mol |
| Topological Polar Surface Area | 80.7 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 560 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Netoglitazone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Netoglitazone, including repackagers and relabelers. The FDA regulates Netoglitazone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Netoglitazone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Netoglitazone supplier is an individual or a company that provides Netoglitazone active pharmaceutical ingredient (API) or Netoglitazone finished formulations upon request. The Netoglitazone suppliers may include Netoglitazone API manufacturers, exporters, distributors and traders.
click here to find a list of Netoglitazone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Netoglitazone DMF (Drug Master File) is a document detailing the whole manufacturing process of Netoglitazone active pharmaceutical ingredient (API) in detail. Different forms of Netoglitazone DMFs exist exist since differing nations have different regulations, such as Netoglitazone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Netoglitazone DMF submitted to regulatory agencies in the US is known as a USDMF. Netoglitazone USDMF includes data on Netoglitazone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Netoglitazone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Netoglitazone suppliers with USDMF on PharmaCompass.
Netoglitazone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Netoglitazone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Netoglitazone GMP manufacturer or Netoglitazone GMP API supplier for your needs.
A Netoglitazone CoA (Certificate of Analysis) is a formal document that attests to Netoglitazone's compliance with Netoglitazone specifications and serves as a tool for batch-level quality control.
Netoglitazone CoA mostly includes findings from lab analyses of a specific batch. For each Netoglitazone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Netoglitazone may be tested according to a variety of international standards, such as European Pharmacopoeia (Netoglitazone EP), Netoglitazone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Netoglitazone USP).
LOOKING FOR A SUPPLIER?
